Study of balance and gait deficits associated with vestibulopathy is important for improving clinical care and is critical to our understanding of the vestibular contributions to gait and balance control. Previous studies report a speed-dependency of the vestibular contributions to gait, so we examined the walking speed effects on gait variability in healthy adults and in adults with bilateral vestibulopathy (BVP). Forty four people with BVP and 12 healthy adults completed walking trials at 0.4m/s to 1.6m/s in 0.2m/s intervals on a dual belt, instrumented treadmill. Using a motion capture system and kinematic data, the means and coefficients of variation for step length, time, width and double support time were calculated. The BVP group also completed a video head impulse test and examinations of ocular and cervical vestibular evoked myogenic potentials and dynamic visual acuity.
Introduction
Ever since a chance observation of a dog with acute unilateral vestibulopathy who demonstrated less imbalance during running than during walking (Brandt et al. 1999) , the interactions of gait velocity, imbalance and vestibular symptoms in people with vestibulopathy have become a topic of great interest. Inspired by the observation in the dog, Brandt et al. (1999) demonstrated with a simple setup that humans with acute unilateral vestibulopathy could run with less deviation to the affected side than while walking. Since then, three studies have reported reductions in temporal gait variability and reductions in stride length variability in bilateral vestibulopathy (BVP) during faster, compared to slower walking Schniepp et al. 2012; Wuehr et al. 2016 ). However, the same studies revealed that patients with BVP do not self-select walking speeds that minimize temporal or spatial gait variability Schniepp et al. 2012; Wuehr et al. 2016) , which may suggest that these are not the only source of instability or inefficiency with which people with BVP must cope. BVP, a severe bilateral reduction of vestibular function that results in severe balance deficits and an increased risk of falls (Guinand et al. 2012a; Horak et al. 2016; Lucieer et al. 2016; Schlick et al. 2016; Sprenger et al. 2017; , was recently defined by the Bárány Society ) and represents one of the most debilitating vestibular disorders. The study of the severe balance and gait deficits in people with BVP is both important for improving clinical care and for objective quantification of the effects of novel interventions, such as vestibular implants Lewis 2016) . Furthermore, it is fundamental to our understanding of the vestibular contributions to gait and balance control.
There are a number of changes in the control of gait with changes in walking speed that partly explain the above described findings and will affect walking speed selection in people with vestibulopathy. The reduction in sagittal plane spatial variability with increasing speed can partly be explained by passive dynamics (Collins et al. 2005; Kuo 2007; McGeer 1993) . Additionally, changes in muscle activation (den Otter et al. 2004; Murley et al. 2014; Raffalt et al. 2017; Savelberg et al. 2010 ) and modular locomotor control (Ogawa et al. 2015; Yokoyama et al. 2016; Yokoyama et al. 2017 ) with changes in walking speed have been observed. Furthermore, less utilization of real-time sensory feedback at faster walking speeds may also affect changes in gait variability; visual (Jahn et al. 2001; Wuehr et al. 2013 ) and vestibular (Fitzpatrick et al. 1999; Jahn et al. 2000) perturbations have less impact on direction and variability at higher speeds, with the exception of step width variability, which appears to be more affected by visual perturbation at faster walking speeds (Wuehr et al. 2013) . It has also been reported that the vestibular influence on lower limb muscles is selectively suppressed with increased cadence and speed during walking (Dakin et al. 2013; Forbes et al. 2017 ), purported to be related to a shift in the control mechanisms of mediolateral stability with increasing walking speeds from active stabilization at the lower limb joints during the stance phase to foot placement (Bauby and Kuo 2000; Dakin et al. 2013) . Despite selective suppression of the vestibular influence on some lower limb muscles at faster walking speeds, significant increases in frontal spatial variability with increasing walking speeds have been reported in BVP , suggesting that vestibular information remains important for mediolateral stability during gait at faster speeds.
In order to further investigate the walking speed dependency of gait variability in vestibulopathy, this study analyzed the gait of people with BVP and of healthy control participants. We aimed to determine the effects of systematic increases in walking speed on spatiotemporal gait parameters and their variability in these participant groups. Secondly, we aimed to assess if these parameters would differentiate between healthy participants, and participants with BVP who could and could not complete all of the planned walking speed trials (used here as a simple proxy of locomotor capacity; see Methods). We hypothesized that, for all participants, temporal and sagittal plane spatial gait variability would systematically reduce with increases in walking speed, whereas frontal plane spatial gait variability would systematically increase, in agreement with previous work. We further postulated that temporal and sagittal plane spatial gait variability at slower walking speeds would be most distinguishing between the healthy control participants, the patients with BVP that could complete the measurement protocol, and the patients with BVP that could only partially complete the measurement protocol, whereas frontal plane spatial gait variability would be most distinguishing between all three groups at faster walking speeds. Gait variability in BVP was generally not correlated with the clinical tests of vestibular function. The current findings indicate that analysis of gait variability at multiple speeds has potential as an assessment tool for vestibular interventions.
Materials and Methods

Participants
Forty four people with BVP participated in this study (22 males, 22 females; age: 57.6±11.5 years; height:
174.5±9.7cm; weight: 80.4±17kg). Inclusion criteria were a prior diagnosis of bilateral vestibular hypofunction at the Maastricht University Medical Centre+ (imbalance and/or oscillopsia during locomotion and summated slow phase mean peak velocity of the nystagmus of less than 20°/s during bithermal caloric tests) and the self-reported ability to walk independently without assistance. Please note that this study began prior to the publication of the Bárány Society guidelines , which are slightly different. Potential participants were not included if they were unable or unwilling to stop taking anxiety or depression medication for the week before the measurements. In addition, a healthy control group comprised of 12 healthy adults (5 males, 7 females; 25.1±2.8 years; 174.9±7.3cm; 72.6±13.5kg) with no history of balance or gait difficulties and no history of dizziness participated in this study. The study was explained before obtaining written informed consent, was conducted in accordance with the Declaration of Helsinki and was approved by the Maastricht University Medical Centre medical ethics committee (gait measurements: NL58205.068.16; vestibular tests: NL52768.068.15).
Gait Analysis Setup, Data Processing and Procedure
The gait measurements were conducted using the Computer Assisted Rehabilitation Environment Extended (CAREN; Motekforce Link, Amsterdam, The Netherlands), which includes a dual-belt force plate-instrumented treadmill (Motekforce Link, Amsterdam, The Netherlands; 1000Hz), a 12 camera motion capture system (100Hz; Vicon Motion Systems, Oxford, UK) and a virtual environment (city-style street with passing objects and structures) projected onto a 180 degrees curved screen (note that optic flow was turned off for the participants with BVP to prevent dizziness and nausea). For all measurement sessions, a safety harness connected to an overhead frame was used. At the request of some of the participants with BVP, a handrail was also positioned on the treadmill, the use of which was monitored and recorded. Six retroreflective markers were attached to anatomical landmarks (C7, sacrum, left and right trochanter and left and right hallux) and were tracked by the motion capture system. Marker tracks were filtered using a low pass second order Butterworth filter (zero-phase) with a 12Hz cutoff frequency. Foot touchdown was determined using combined force plate (50N threshold) and foot marker data (Zeni et al. 2008 ). This combined method was used to be able to accurately account for foot touchdowns and toeoffs occurring in the center of the treadmill triggering both force plates simultaneously. For these steps, the foot marker method was used and then corrected based on the average discrepancy between the force plate method and the marker method timing for all steps that contacted only one force plate. The spatiotemporal gait parameters of interest were step length (anteroposterior distance between the hallux markers at foot touchdown), step time (time from touchdown of one foot to touchdown of the next foot), step width (mediolateral distance between the hallux markers at foot touchdown) and double support time (time spent with both feet on the ground). Means, standard deviations and coefficients of variation (CV) were determined for each speed for each participant.
Each session began with walking familiarization trials at 0.4m/s up to 1.6m/s in 0.2m/s intervals. At least 60s were used for each speed, and further time was provided to familiarize to each speed if deemed necessary by either the participant, the CAREN operator or the research clinician. At the end of each speed trial, the decision to continue to the next (faster) speed was made in a similar manner. If the patient was not comfortable progressing to the next speed or if the CAREN operator or research clinician did not think it was safe or feasible to progress, then the participant continued at the current speed instead. Participants were then given sufficient rest before continuing with the measurements. Single two-to-three minute long measurements (to ensure a minimum of 60 strides per speed) were then conducted at each prescribed speed that was completed during familiarization.
Multiple set walking speeds were used as opposed to the majority of previous studies which have used either percentages of preferred walking speeds or self-perceived slow, normal and fast walking speeds, in order to have more control over the walking speed condition.
Clinical Vestibular Function Tests Setup and Procedures
We aimed to conduct an explorative analysis in the patient groups by examining correlations between the outcomes of the most distinguishing gait parameters identified and clinical vestibular tests (video head impulse test [vHIT] , ocular and cervical vestibular evoked myogenic potentials [oVEMP and cVEMP] and dynamic visual acuity [DVA] ) that are indicative of vestibular functional integrity.
The vHIT was performed with the EyeSeeCam system (EyeSeeCam VOG; Munich, Germany) and the ICS Impulse system (GN Otometrics A/S, Denmark). Both systems measured the movement of the right eye. The distance of the back of the static chair was 2 meters to the point of fixation. The point of fixation consisted of a green dot on the wall, produced by a laser on a tripod. If necessary, adhesive plasters were used to lift the upper eyelid a little to secure the visibility of the pupil for the camera in all directions. Goggle movement was minimized by adjusting the strap of the goggles to every subject. The vHIT system was calibrated according to the protocol of the system. After calibration, the subject was instructed to not touch their head including the goggles. The examiner stood behind the participant with two hands firmly on top of the participant's head without touching the strap of the goggles. The examiner then applied head impulses in six different movements to test each canal (McGarvie et al. 2015) . The horizontal head impulses comprised a peak velocity of > 150°/s and the vertical head impulses a peak head velocity of > 100°/s. The amplitude of the movements was 10-20°. Only outward impulses were used (van Dooren et al. 2018) . The vHIT was defined as abnormal if the VOR-gain was below 0.7 and/or if covert saccades were observed in 50% or more of the traces (McGarvie et al. 2015; Yip et al. 2016) .
DVA was assessed on a regular treadmill (1210 model, SportsArt, Inc., Tainan, Taiwan, China.) with the participant positioned 2.8 meters from a computer screen. Firstly, the static visual acuity was determined during stance, followed by the assessment of the DVA during walking at 2, 4 and 6 km/h. One letter at a time was randomly displayed on the screen from a chart of Sloan letters (CDHKNORSVZ; Sloan 1959 ). Starting at a logMAR (log of the Minimum Angle of Resolution; (Bailey and Lovie 1976) ) of 1.0, five random letters were shown at each logMAR (decreasing in steps of 0.1 logMAR). When four out of five letters were correctly identified, the corresponding logMAR was considered achieved. The outcome of the DVA was the difference between the static logMAR and the logMAR for each of the three walking speeds. The result was omitted if the subject needed a handrail to walk at that speed or if it wasn't possible to walk at that speed at all (Guinand et al. 2012b ).
cVEMP and oVEMP were assessed with the Neuro-Audio system (v2010, Neurosoft, Ivanovo, Russia).
A monaural stimulation with in-ear earphones was used with air conduction tone bursts at 500Hz and a stimulation rate of 13Hz using a blackman window function with a two-cycle rise/fall and no plateau phase. Tone bursts of maximum 130dB sound pressure level (SPL) were used. A stepwise approach was used to determine the threshold with a precision of 5dB SPL . Positive (P1) and negative (N1) peaks in the recorded biphasic waveform were marked for both cVEMPs and oVEMPs. The thresholds were determined as the lowest stimulus intensities to elicit recognizable peaks. If it wasn't possible to find a VEMP response, it was defined as a threshold of >130dB SPL. For the cVEMP, the participant was positioned lying down with the back positioned at a 30° angle above the horizontal plane and was asked to turn their head towards the non-measured side and lift there head during the measurement. The cVEMP was recorded at the ipsilateral sternocleidomastoid muscle. Two electrodes were placed on the sternocleidomastoid muscles, the reference electrode on the sternum, and the earth electrode on the forehead. Electrode impedances of 5 kΩ or lower were accepted and otherwise the electrode was replaced. To ensure correct muscle contraction, a feedback system using a screen was provided. An average of 200 EMG traces with a minimum mean rectified voltage (MRV) of 65µV and a maximum MRV of 205µV was accepted (Brantberg and Lofqvist 2007; Fujimoto et al. 2009 ). The oVEMP was recorded at the contralateral inferior oblique muscle. Five electrodes were used: the recording electrodes beneath the eyelid, just lateral of the pupil when gazing forward and centrally, the reference electrodes beneath the recording electrode and the earth electrode on the forehead. The participant was asked to keep their gaze at a focus point placed at a 30 degrees angle behind the head. An average of at least 300 EMG traces was accepted (Govender et al. 2011; Piker et al. 2013; Valko et al. 2016) .
Statistics
From the 44 participants with BVP that started the study, three groups were formed. One group was able to complete all of the gait measurements without assistance (BVP All Gait; n=26), the second was only able to complete some of the speeds without assistance (BVP Part Gait; n=12; all of this group were able to complete the measurements at least up to 0.8m/s) and the final group (BVP No Gait; n=6) did not start the recorded gait trials (see "Results" for details on this group).
To investigate the effects of walking speed on gait and this effect's potential interaction with vestibular function, a two way repeated measures ANOVA with walking speed (0.4 to 1.6m/s) and group (healthy control and BVP All Gait) as factors was conducted for the means and CVs of step time and length, step width and double support time. To further investigate the potential of the gait parameters to distinguish between groups, a two way repeated measures ANOVA with walking speed (0.4 to 0.8m/s) and group (healthy control, BVP All Gait and BVP Part Gait) as factors was conducted for the means and CVs of step time and length, step width and double support time. Bonferroni post hoc tests were performed when significant effects or interactions were found with the ANOVAs.
The vHIT testing revealed abnormal canal function in all or most directions for almost all of the participants with BVP (i.e. exceptions were two participants with BVP who had only one abnormal result out of six). As almost all outcomes were abnormal and there was no possibility to distinguish between groups, analysis of the vHIT results in relation to gait was not taken further. For all completed DVA trials with a logMAR change value during the three walking speeds compared to standing and when oVEMP or cVEMP thresholds were detected, these values were grouped and Pearson correlations with the gait parameters that were most distinguishing between the groups were conducted (see Results). Age, height, weight and body mass index (BMI) were compared across the three BVP groups (BVP All Gait, BVP Part Gait, BVP No Gait) using one way ANOVAs with Bonferroni corrections for multiple comparisons.
Results
Twenty six participants with BVP were able to complete all of the gait measurements without assistance (BVP All Gait). Twelve participants with BVP were only able to complete some of the speeds (BVP Part Gait), of which one participant stopped after 0.8m/s, one after 1.0m/s, four after 1.2m/s and six after 1.4m/s. Six participants with BVP were assigned to the BVP No Gait group for the following reasons: one participant became dizzy and nauseated during familiarization and could not continue; three participants were not able to walk during familiarization without handrail support; two participants found treadmill walking too challenging and could not continue. The demographic data of these three groups, as well as the healthy control group can be found in Table   1 . No significant differences in demographics were found between the BVP groups. 169.7 ± 9 79.9 ± 18 27.6 ± 4.7 BVP No Gait 6 (2 female) 65.3 ± 13.6 174 ± 6.9 82.4 ± 13.4 27.2 ± 3.8 Values are means ± SD The two way repeated measures ANOVA with walking speed (0.4 to 1.6m/s) and group (healthy control and BVP All Gait) as factors revealed significant walking speed effects for the means and CV of step time and length, step width and double support time (P<0.0001), significant group effects for all parameters except step width means (P≤0.0068) and significant walking speed by group interactions for the means of step time, double support time and step width (P≤0.001) and the CV of step width (P<0.0001). The ANOVA results and betweengroup Bonferroni post-hoc test results are displayed in Fig. 1 . When cVEMP and oVEMP thresholds were detected, and when a speed of the DVA was completed, these values were taken and Pearson correlations were conducted with the CVs of step time, step length and double support time at 0.4m/s and the CV of step width at 1.6m/s, being the most distinguishing gait parameters from the previous analysis. These results can be seen in Table 2 . 
Post-hoc Analysis of Gait Data based on VEMP Results
In order to further investigate differences within the patient group, we conducted an analysis of the gait data of the participants with and without at least one detected VEMP threshold and compared these to the healthy participant data for the same four parameters as the correlations: the CVs of step time, step length and double support time at 0.4m/s and the CV of step width at 1.6m/s. Given that all of the participants with no VEMP threshold detected also had abnormal outcomes on the vHIT for most or all of the six directions tested, the purpose of this analysis was to compare the gait of participants with and without detectable canal and otolith function. One way ANOVAs with Bonferroni corrections did not reveal any significant differences between the participants with and without at least one detectable VEMP threshold (0.2526<P<0.9999).
Discussion
In this study, we aimed to determine the effects of systematic increases in walking speed on spatiotemporal gait parameters and their variability in people with BVP. Specifically, we investigated if these parameters would distinguish between healthy participants and participants with BVP who could and could not complete all of the planned walking speed trials (a simple proxy of locomotor capacity). Our hypothesis, that temporal and sagittal plane spatial gait variability would systematically reduce with increases in walking speed, whereas frontal plane spatial gait variability would systematically increase, was confirmed as significant effects of walking speed were found both when considering all of the assessed speeds in those participants who completed the protocol, as well as when only considering the three slowest walking speeds. We additionally hypothesized that temporal and sagittal plane spatial gait variability at slower walking speeds would be most distinguishing between the healthy control participants, the patients with BVP that could complete the measurement protocol, and the patients with BVP that could only partially complete the measurement protocol, whereas frontal plane spatial gait variability would be most distinguishing between these groups at faster walking speeds. This hypothesis was also confirmed, although frontal plane spatial variability was more distinguishing in the analysis including the faster walking speeds.
Our secondary aim was to conduct an explorative analysis in the patient groups by examining correlations between the outcomes of four clinical vestibular tests (vHIT, oVEMP, cVEMP, DVA) and the most distinguishing gait parameters identified. Only one significant correlations between the change in logMAR scores during the DVA and the gait parameters were found (6km/h and Double Support CV; Table 2 ). One significant correlation of 16 was found between the VEMP thresholds and the gait parameters, but only nine pairs of data were included in this test and if a Bonferroni correction is made for the p values of these 16 tests, it is no longer significant (oVEMP Left and
Step Length CV at 0.4m/s; Table 2 ). Even though this study clearly demonstrates the significant contribution of vestibular function to gait (difference between healthy and BVP groups), our exploratory analysis confirms the complex contribution of vestibular information during every-day activities and the difficulty in translating current objective clinical measures to highly relevant patient symptoms.
Determining meaningful and distinguishing gait parameters in BVP is vital for the development of interventions, as is using tasks that sufficiently replicate the day-to-day challenges of these patients, in order to determine candidates for intervention and to assess the effect of those interventions. Two promising interventions currently under development and investigation include noisy galvanic vestibular stimulation (nGVS) and vestibular implants (Guinand et al. 2015; Lewis 2016; Perez Fornos et al. 2017; Wuehr et al. 2017 ). Discussions of these treatment options can be found elsewhere Wuehr et al. 2017 ), but in the context of this study, it is important to note that both options show early signs of utility for improving the gait of people with BVP (McCrum et al. 2016; Wuehr et al. 2016) . However, it remains to be seen if improvement due to nGVS or a vestibular implant in steady state gait would likewise be seen in more dynamic locomotor task performance, where even unilateral vestibulopathy leads to significantly poorer stability performance (McCrum et al. 2014 ). Related to this, it should be noted that while this study examined spatiotemporal variability, differences in dynamic gait stability were not directly assessed and the two are not necessarily equivalent (Bruijn et al. 2013; Dingwell et al. 2001; Perry and Srinivasan 2017) . The parameters presented here represent the amount of variability in particular gait parameters, but do not necessarily indicate the overall stability of the participants.
Therefore, future work should investigate how dynamic gait stability is altered in BVP and how this is affected by changes in walking speed.
The current study confirmed previous findings of reductions in temporal gait variability and reductions in sagittal plane spatial gait variability in vestibulopathy during faster, compared to slower walking Schniepp et al. 2012; Wuehr et al. 2016) . We extend these previous findings as the current study employed fixed (not self-selected) speeds that were systematically increased, with 120 steps analyzed per speed, thereby improving the reliability of the outcomes. Importantly, the current results further the previous findings by additionally showing that these parameters are related to the locomotor capacities of people with BVP.
We also confirmed previously reported increases in frontal plane spatial variability with increasing walking speeds in people with BVP . Previous studies have shown that vestibular perturbations have less impact on direction and variability at higher walking speeds (Fitzpatrick et al. 1999; Jahn et al. 2000) and that the vestibular influence on lower limb muscles is selectively suppressed with increased cadence and speed during walking (Dakin et al. 2013; Forbes et al. 2017) . However, the current step width variability results, combined with those of suggest that vestibular information remains important for mediolateral stabilization at increased walking speeds. These results also provide some explanation as to why people with BVP do not self-select walking speeds that minimize temporal or sagittal plane spatial gait variability Schniepp et al. 2012; Wuehr et al. 2016) . Dramatic increases in step width variability may be undesirable due to reduced stability control or increased energetic costs of mediolateral stabilization (Dean et al. 2007; Donelan et al. 2004; O'Connor et al. 2012) . Based on the current results, either reason is plausible, as some of the participants in the BVP Part Gait group did not continue to the faster speeds due to instability, while others could not continue due to being unable to keep up with the speed of the treadmill (implying an energetic or physiological limitation, not a stability-related one). The vestibular influence on gait economy has not yet, to our knowledge, been thoroughly investigated, and is therefore an area for future research.
The healthy control group in this study was not age matched with the BVP group and there were nonsignificant age differences between the three BVP groups. However, we do not think that this would influence our findings as a number of studies have shown that gait variability (the focus of the current study) in healthy young and older adults is not significantly affected by (healthy) ageing (Herssens et al. 2018; Hollman et al. 2011 ).
However, other limitations in the current study should be kept in mind. Caution should be taken in comparing the CV of step width to studies of overground walking, as it has been shown previously in healthy participants that walking on the CAREN results in increased step width variability compared to overground walking (Gates et al. 2012 ). Additionally, treadmill walking appears to be more challenging than overground walking for people with BVP, evidenced by the fact that the BVP No Gait group were not able to successfully complete the familiarization period, despite reporting being able to walking independently without assistance. We would therefore caution a direct comparison of treadmill-derived gait results with overground gait results in BVP. Regarding the fact that the healthy group walked with optic flow and the BVP group walked with the virtual environment fixed (so as to provide the same lighting), we do not expect that this difference would have altered our results, as two previous studies found no, or negligible, differences in the parameters assessed here between fixed speed walking with and without virtual reality (Katsavelis et al. 2010; Sloot et al. 2014 ).
We also acknowledge that our division of participants into the BVP All Gait and BVP Part Gait groups is based on a rather simple criterion. Of the 12 participants in the BVP Part Gait group, one participant stopped after 0.8m/s, one after 1.0m/s, four after 1.2m/s and six after 1.4m/s and therefore, the range of locomotor capacities within this group is likely broad. Reasons for lack of completion also varied across the participants, with some stopping due to lack of stability control (too much lateral deviation with a risk of stepping off the treadmill) and others unable to keep up with a faster belt speed. However, these two groups demonstrated differences in the CVs of step time, step length and double support time (Fig. 2) , strengthening the findings from the healthy control and BVP All Gait comparison, in that these parameters not only distinguished between healthy and BVP groups, but also within the BVP groups.
In conclusion, spatiotemporal gait parameters and their variability show speed-dependency in people with BVP and in healthy adults, and this was seen both when considering all of the assessed speeds in those participants who completed the protocol, as well as when only considering the three slowest walking speeds. Temporal and sagittal plane spatial gait variability at slower walking speeds and frontal plane spatial gait variability at faster walking speeds were the most distinguishing parameters between the healthy participants and people with BVP who have different locomotor capacities. Gait variability in BVP was generally not correlated with the clinical tests of vestibular function. The current findings indicate that analysis of gait variability at multiple speeds has potential as an assessment tool for vestibular interventions.
